封面
市场调查报告书
商品编码
1535218

植入式心臟整流去颤器(ICD)市场:各市场区隔规模,占有率,法律规章,偿付,手术,2033年为止的预测

Implantable Cardioverter Defibrillators (ICD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

植入式心律转復除颤器 (ICD) 是一种电子设备,可监测心律,并在检测到心律不整(心跳不规则)时发出电脉衝以恢復心臟的自然节律。 ICD 包含三个主要部分:脉衝产生器、电极和引线。但也有不带引线的类型。

心臟骤停或心臟骤停 (SCA) 是指心臟因节律异常(例如心室颤动或室性心动过速)而无法将血液泵送到身体重要器官的情况。通常,这些异常节律是短暂且无害的。某些危险因素,如高血压、肥胖、高胆固醇和糖尿病,会增加 SCA 的可能性。心臟骤停的唯一治疗方法是去颤以恢復心臟功能,可以使用体外去颤器来完成,但存活的机会很低。医师可能会为 SCA 高风险患者(例如患有冠状动脉疾病或心肌病变的患者)开立抗心律不整药物或植入式心臟復律去颤器。最初的植入式心臟復律去颤器仅设计用于侦测心室颤动,而不会侦测到室性心搏过速。 ICD 用于记录心臟活动并向心臟传送电击或脉衝以治疗危险的室性心律不整。

本报告提供全球植入式心臟整流去颤器(ICD)市场相关资料详细考察,提供市场上竞争情形,SWOT分析,到2033年为止的市场预测,地区,各国的趋势等资讯。

目录

已上市的植入式心臟整流去颤器(ICD)和不断变化的竞争格局

  • 主要的产业趋势洞察
  • 植入式心臟整流去颤器(ICD)的各市场区隔整体市场收益和2015年~2033年的市场展望
  • 各市场区隔的手术总数,台数,平均销售价格,市场价值相关详细资料

世界,地区,各国洞察

  • 植入式心臟整流去颤器(ICD)市场SWOT分析
  • 植入式心臟整流去颤器(ICD)市场相关竞争动态的洞察和趋势
  • 各国医疗制度概要
  • 各国偿付政策
  • 各国医疗技术相关法规状况
简介目录
Product Code: GDME662MM

Implantable Cardioverter Defibrillators (ICD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart's rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart's natural rhythm. ICDs contain three main components: a pulse generator, electrodes, and leads. However, the devices can also be leadless.

Cardiac Arrest or Sudden Cardiac Arrest (SCA) is a condition in which abnormal rhythms like Ventricular Fibrillation and Ventricular Tachycardia prevents the heart from pumping blood to the vital organs of the body. Often these abnormal rhythms are momentary and harmless. Certain risk factors such as high blood pressure, obesity, high blood cholesterol, diabetes etc., can increase the chances of SCA. The only treatment of cardiac arrest is to defibrillate the heart to restore heart function which can be done using an external defibrillator, however, the chances of surviving an out of hospital cardiac arrest are thin. For patients with high risk of SCA, such as those with coronary artery disease or cardiomyopathy, a physician may prescribe anti-arrhythmic medication or an Implantable Cardioverter Defibrillator. The original implantable cardioverter-defibrillator was designed to detect only ventricular fibrillation and not for ventricular tachycardia. ICDs are used to record the heart's activity and treat dangerous ventricular arrhythmias with an electrical shock or pulse to the heart.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Implantable Cardioverter Defibrillators (ICD) and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Implantable Cardioverter Defibrillators (ICD) market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Implantable Cardioverter Defibrillators (ICD) market.
  • Competitive dynamics insights and trends provided for Implantable Cardioverter Defibrillators (ICD) market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, Biotronik SE & Co KG, MicroPort Scientific Corp.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Implantable Cardioverter Defibrillators (ICD) marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
  • Develop business strategies by understanding the trends shaping and driving Implantable Cardioverter Defibrillators (ICD) market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Implantable Cardioverter Defibrillators (ICD) market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Implantable Cardioverter Defibrillators (ICD) market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.